These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32458666)

  • 21. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry.
    Chiang FT; Shyu KG; Wu CJ; Mar GY; Hou CJ; Li AH; Wen MS; Lai WT; Lin SJ; Kuo CT; Kuo C; Li YH; Hwang JJ;
    J Formos Med Assoc; 2014 Nov; 113(11):794-802. PubMed ID: 24076272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Acute Coronary Syndrome Treatment and Prognosis After Implementation of the Infarction Code in a Hospital With a Cardiac Catheterization Unit.
    Cordero A; López-Palop R; Carrillo P; Frutos A; Miralles S; Gunturiz C; García-Carrilero M; Bertomeu-Martínez V
    Rev Esp Cardiol (Engl Ed); 2016 Aug; 69(8):754-9. PubMed ID: 26979766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends and predictors of recurrent acute coronary syndrome hospitalizations and unplanned revascularization after index acute myocardial infarction treated with percutaneous coronary intervention.
    Yudi MB; Clark DJ; Farouque O; Andrianopoulos N; Ajani AE; Brennan A; Lefkovits J; Freeman M; Hiew C; Selkrig LA; O'Brien J; Dart AM; Reid CM; Duffy SJ;
    Am Heart J; 2019 Jun; 212():134-143. PubMed ID: 31004916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease.
    Gyldenkerne C; Olesen KKW; Madsen M; Thim T; Jensen LO; Raungaard B; Sørensen HT; Bøtker HE; Maeng M
    Diab Vasc Dis Res; 2019 Jul; 16(4):351-359. PubMed ID: 30939916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive glucose control for acute myocardial infarction--reply.
    de Mulder M; Umans VA; Boersma E
    JAMA Intern Med; 2014 May; 174(5):826-7. PubMed ID: 24799015
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine.
    Rhoads GG; Kosiborod M; Nesto RW; Fonseca VA; Lu SE; Zhang Q; Foody JM
    Am J Cardiol; 2009 Oct; 104(7):910-6. PubMed ID: 19766755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
    Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
    Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.
    Norhammar A; Malmberg K; Rydén L; Tornvall P; Stenestrand U; Wallentin L;
    Eur Heart J; 2003 May; 24(9):838-44. PubMed ID: 12727151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to guidelines for pharmacological treatment of young adults with myocardial infarction in Poland: Data from Polish Registry of Acute Coronary Syndromes (PL-ACS).
    Lisowska A; Makarewicz-Wujec M; Dworakowska AM; Kozłowska-Wojciechowska M
    J Clin Pharm Ther; 2019 Jun; 44(3):471-478. PubMed ID: 30763467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a New Risk Score for Predicting Post-discharge Cardiovascular Events in Patients With Acute Coronary Syndrome.
    Manzano-Fernández S; Flores-Blanco PJ; Gómez-Molina M; López-Cuenca ÁA; Sánchez-Galian MJ; Valdés M
    Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):338-40. PubMed ID: 26778589
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study.
    Horsdal HT; Søndergaard F; Johnsen SP; Rungby J
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):331-7. PubMed ID: 21442682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
    Lincoff AM; Tardif JC; Schwartz GG; Nicholls SJ; Rydén L; Neal B; Malmberg K; Wedel H; Buse JB; Henry RR; Weichert A; Cannata R; Svensson A; Volz D; Grobbee DE;
    JAMA; 2014 Apr; 311(15):1515-25. PubMed ID: 24682069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-cause readmission and repeat revascularization after percutaneous coronary intervention.
    Przybysz-Zdunek B; Ploch M; Pluta W; Dada M; Opolski G
    Cardiol J; 2012; 19(2):174-9. PubMed ID: 22461051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
    Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
    Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project.
    Zhou M; Liu J; Hao Y; Liu J; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Yang N; Xing Y; Zhao D;
    Cardiovasc Diabetol; 2018 Nov; 17(1):147. PubMed ID: 30482187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome.
    Morici N; Savonitto S; Ponticelli C; Schrieks IC; Nozza A; Cosentino F; Stähli BE; Perrone Filardi P; Schwartz GG; Mellbin L; Lincoff AM; Tardif JC; Grobbee DE
    Am J Med; 2017 Sep; 130(9):1068-1075. PubMed ID: 28344139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
    Xian Y; Wang TY; McCoy LA; Effron MB; Henry TD; Bach RG; Zettler ME; Baker BA; Fonarow GC; Peterson ED
    Circulation; 2015 Jul; 132(3):174-81. PubMed ID: 25995313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.